Scientist may have made an important breakthrough in the future prevention of prostate cancer.
The findings, reported in the most recent edition of the International journal of Cancer (IJC), show that gamma-tocotrienol kills prostate cancer stem cells, which cause the initiation of prostate cancer and are resistant to existing chemotherapy drugs. A member of the vitamin E family, gamma-tocotrienol is found naturally in palm oil.
“These results provide a compelling case for developing the potential of gamma-tocotrienols to help patients with terminal hormonal refractory prostate cancer. The prospects of future studies on the cancer-fighting effects of gamma-tocotrienols are exciting indeed and we see increasing research interest by scientists in this area,” said Mr. Arthur Ling, CEO of Davos Life Science Singapore.